Gene Therapy Breakthrough: Linear DNA-Chitosan Nanoparticles Show Promise in Pulmonary Gene Delivery

Researchers from the University of Pisa have made a significant breakthrough in the field of gene therapy by developing linear DNA-chitosan nanoparticles that show great potential in pulmonary gene delivery. According to a new study published in the journal Applied Biosciences, these nanoparticles exhibit excellent transfection efficiency and stability, making them an effective choice for gene delivery pilot studies. The researchers also demonstrated the cellular internalization and protein expression of the nanoparticles in human pulmonary distal lung cells.

Key Takeaways:

• The study used linear DNA constructs, which are integrated into the mammalian genome and offer stable transgene expression, compared to circular plasmids.
• The development of DNA-chitosan nanoparticles has gained significant interest for their potential in nucleic acid delivery, especially as non-viral gene delivery systems.
• The optimal formulation of linear DNA-loaded chitosan nanoparticles exhibited a size of approximately 290 nm, an encapsulation efficiency of 86%, and a zeta potential of 25 mV.
• The concentration of DNA in solution influenced nanoparticle formation, encapsulation efficiency, and particle size, with optimal conditions demonstrated for high transfection efficiency.
• The study highlighted the potential of DNA-chitosan NPs in nucleic acid delivery, particularly for pulmonary applications, and demonstrated successful cellular internalization and protein expression in human pulmonary distal lung cells.
• The researchers aim to focus on formulating the achieved carrier into an inhalable dosage form to improve its translational application.

Statistics:

• The size of the optimal formulation of linear DNA-loaded chitosan nanoparticles was approximately 290 nm.
• The encapsulation efficiency of the optimal formulation was 86%.
• The zeta potential of the optimal formulation was 25 mV.
• The study demonstrated successful cellular internalization and protein expression in human pulmonary distal lung cells.

Sources:

• "Linear DNA-Chitosan Nanoparticles: Formulation Challenges and Transfection Efficiency in Lung Cell Line" (Applied Biosciences, 2025, 4(2):29).